GlycoMimetics Inc. (GLYC)
NASDAQ: GLYC
· Real-Time Price · USD
15.71
-0.44 (-2.72%)
At close: Jul 02, 2025, 3:58 PM
GlycoMimetics Revenue Breakdown
Period Ending | Jun 30, 2025 |
---|---|
Reportable Segment Revenue | 2.79M |
Reportable Segment Revenue Growth | n/a |
Operating Expense Breakdown
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 8.95M | 2.38M | 5.08M | 4.01M | 4.07M | 5.09M | 4.31M | 4.52M | 4.86M | 5.52M | 4.73M | 3.85M | 5.46M | 5.06M | 4.55M | 4.14M | 4.24M | 4.19M | 4.01M | 4.06M | 4.24M | 4.44M | 3.87M | 3.38M | 3.75M | 3.36M | 2.92M | 2.79M | 2.85K | 2.85M | 2.82M | 2.4M | 2.52M | 2.09M | 2.3M | 1.98M | 2.31M | 2.06M | 1.96M | 2.13M | 1.81M | 1.91M |
Selling, General, and Administrative Revenue Growth | +275.36% | -53.08% | +26.83% | -1.62% | -19.99% | +18.03% | -4.64% | -6.90% | -12.04% | +16.69% | +23.07% | -29.51% | +7.89% | +11.17% | +9.80% | -2.24% | +1.17% | +4.41% | -1.16% | -4.18% | -4.62% | +14.79% | +14.40% | -9.86% | +11.64% | +15.03% | +4.70% | +97897.89% | -99.90% | +1.38% | +17.24% | -4.76% | +20.55% | -8.96% | +15.83% | -14.19% | +12.45% | +4.79% | -8.02% | +18.11% | -5.20% | n/a |
Research and Development Revenue | 12.08M | 14.78K | 233.21K | 1.72M | 6.29M | 6.03M | 5.29M | 5.29M | 4.07M | 5.42M | 5.89M | 4.92M | 7.97M | 9.6M | 12.9M | 13.28M | 10.17M | 11.15M | 11.72M | 10.67M | 9.87M | 12.67M | 11.47M | 10.72M | 13.07M | 11.77M | 12.04M | 9.73M | 9.3M | 9.02M | 6.72M | 5.78M | 5.72M | 5.88M | 6.06M | 5.92M | 5.78M | 5.52M | 6.96M | 5.04M | 7.84M | 5.21M |
Research and Development Revenue Growth | +81660.96% | -93.66% | -86.40% | -72.71% | +4.32% | +13.92% | -0.05% | +29.93% | -24.84% | -8.02% | +19.67% | -38.26% | -16.98% | -25.53% | -2.90% | +30.63% | -8.79% | -4.89% | +9.84% | +8.09% | -22.08% | +10.48% | +6.93% | -17.92% | +10.98% | -2.21% | +23.74% | +4.59% | +3.11% | +34.25% | +16.26% | +1.01% | -2.66% | -2.99% | +2.34% | +2.43% | +4.76% | -20.72% | +38.16% | -35.76% | +50.60% | n/a |